Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry
ID: 361002Type: Posted
Overview

Buyer

Centers for Disease Control - NCBDDD (HHS-CDC-NCBDDD)

Award Range

$166K - $489K

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/361002
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled "Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry." This initiative aims to collect high-quality longitudinal data on individuals with spina bifida through specialized clinics and to implement the Urologic Management to Preserve Initial Renal Function Protocol for young children with myelomeningocele. The funding, which ranges from $166,428 to $488,571 per award, totals approximately $2,330,000, with an expected 19 awards to be made. Interested applicants, particularly small businesses, should note that applications are due by March 16, 2026, with an estimated award date of August 11, 2026; for further inquiries, contact Stephanie Griswold at 404-718-2623 or via email at eut6@cdc.gov.

    Point(s) of Contact
    Stephanie Griswold
    (404) 718-2623
    eut6@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan." This initiative aims to gather unique data to enhance understanding of the resources and opportunities necessary to improve outcomes for individuals with autism and Fragile X Syndrome (FXS) throughout their lives. The program consists of three components: data collection on autistic teens and young adults, data collection on individuals with FXS, and dissemination of public health products to support these populations. The total estimated funding for this program is $18 million, with 11 awards expected to be made. Interested applicants can reach out to Seema Gupta at (770) 488-6527 or via email at cvk9@cdc.gov for further information. Applications must be submitted electronically by January 30, 2026, with the project anticipated to start on July 1, 2026.
    Spinal Cord Injury (SCI) Model Systems National Data and Statistical Center
    Administration for Community Living
    The Administration for Community Living is offering a federal grant opportunity titled "Spinal Cord Injury (SCI) Model Systems National Data and Statistical Center." This grant aims to enhance the effectiveness of services under the Rehabilitation Act by developing methods and technologies that improve independent living and employment outcomes for individuals with spinal cord injuries. The selected center will be responsible for maintaining a national longitudinal database, ensuring high-quality data collection, and providing methodological support to SCI Model Systems Centers. The grant has an award ceiling of $800,000 and a floor of $795,000, with a project period of 60 months. Interested applicants can reach out to Radha Holavanahalli at Radha.Holavanahalli@acl.hhs.gov or call 202-795-7321 for more information, and the application deadline is expected to be around April 24, 2026.
    Spinal Cord Injury Model Systems Centers
    Administration for Community Living
    The Administration for Community Living is offering a federal grant opportunity titled "Spinal Cord Injury Model Systems Centers" aimed at supporting a multidisciplinary system of rehabilitation care for individuals with spinal cord injuries (SCI). Eligible applicants include states, public or private agencies, organizations, institutions of higher education, and Indian tribes, provided they can demonstrate a continuum of care for SCI patients, including emergency and post-acute services. This program is crucial for advancing research and improving rehabilitation practices for SCI, with a total estimated funding of $8,446,263 available for approximately 14 awards, ranging from $560,000 to $640,000 each over a 60-month project period. Interested parties can reach out to Brian Bard at 202-795-7298 or via email at Brian.Bard@acl.hhs.gov for further information, and applications must be submitted by April 24, 2026.
    Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement titled "Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases." This initiative aims to enhance the nation's capacity to prevent, detect, and respond to infectious disease threats by supporting healthcare professionals, systems, and organizations involved in public health and patient care. The program emphasizes strengthening critical infrastructure, workforce training, and emergency response capabilities, particularly focusing on antimicrobial resistance and infection control. With an estimated total funding of $150 million, the CDC anticipates awarding approximately 15 grants, with individual awards ranging from $1 million to $30 million. Interested applicants can contact Trisia Shannon at 404-639-0063 or via email at xki5@cdc.gov, with applications due by April 18, 2026, and project start dates expected by September 30, 2026.
    NIH and CDC Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), is offering a Small Business Innovation Research (SBIR) Grant opportunity for United States small business concerns (SBCs) to submit applications for various phases of research and development, including Phase I, Phase II, Direct to Phase II, Fast-Track, and Phase IIB grants. Eligible applicants must possess the necessary research capabilities and technological expertise to support the R&D missions of the NIH and CDC, with a focus on health-related innovations. This funding opportunity is significant as it encourages collaboration among small businesses to advance health research, with applications expected to be solicited following the reauthorization of the SBIR program. Interested parties can reach out to the NIH SEED Office at SEEDinfo@nih.gov or call 301-827-8595 for further information, with the estimated synopsis posting date set for October 1, 2025, and a closing date for applications anticipated on January 5, 2026.
    Comprehensive Suicide Prevention Program for States
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Comprehensive Suicide Prevention Program for States," aimed at implementing and evaluating a comprehensive approach to suicide prevention, particularly for disproportionately affected populations such as veterans, rural communities, and LGBTQ individuals. Eligible applicants must submit proposals with a funding request between $650,000 and $1,200,000, including various letters of commitment and support, as well as a preliminary organizational chart detailing required staff roles. The total estimated program funding is approximately $49.7 million, with an expected 42 awards to be made, and applications must be submitted electronically by 11:59 PM ET on March 3, 2026, with the anticipated award date set for June 19, 2026. For further inquiries, applicants can contact the Comprehensive Suicide Prevention mailbox at csp@cdc.gov.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative seeks applications from bona fide agents representing state, territorial, local, and tribal government organizations, with the goal of implementing effective strategies to combat parasitic diseases. The total estimated program funding is $23,750,000, with individual awards ranging from $250,000 to $1,250,000, and a total of 11 awards expected to be made. Interested applicants should note that the application deadline is June 5, 2026, and they can reach out to Jamal Choice, the Project Officer, at 404.718.8228 or via email at qhi2@cdc.gov for further information.
    Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity for the continuation and expansion of the National Mesothelioma Virtual Bank for Translational Research (U24). This cooperative agreement aims to enhance the collection of biospecimens and related data to support biomedical research on malignant mesothelioma, requiring applicants to have an established registry and tissue bank capable of functioning as a national resource. The initiative is crucial for advancing research into early disease markers, treatment modalities, and improving health outcomes for mesothelioma patients. The total estimated funding for this program is $5.5 million, with a ceiling and floor award amount of $1.1 million, and applications must be submitted electronically by March 23, 2026, with an anticipated award date of August 1, 2026. For further inquiries, interested parties can contact Bridgette Garrett at bgarrett@cdc.gov or by phone at 770-488-5715.
    Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations" through a cooperative agreement. This initiative aims to support research that gathers timely economic data on immunization from nationally representative samples of the public, including patients and caregivers, to inform economic evaluations of new vaccines. The program is critical for understanding productivity losses related to immunization, particularly for vulnerable populations such as pregnant women and parents of young children. The estimated total funding for this program is $1.2 million, with individual awards ranging from $300,000 to $400,000. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836, with applications due by March 31, 2026, and project start anticipated on September 1, 2026.
    Centers of Excellence in Healthcare Quality: Detecting and Responding to Threats to Healthcare Safety
    Centers for Disease Control - NCEZID
    The Centers for Disease Control - NCEZID is offering a federal grant opportunity titled "Centers of Excellence in Healthcare Quality: Detecting and Responding to Threats to Healthcare Safety." This initiative aims to establish a collaborative network among healthcare systems, facilities, and public health partners to enhance the detection, response, and prevention of threats to patient and healthcare worker safety, ultimately improving the quality and resilience of U.S. healthcare delivery. The program is particularly relevant for various healthcare settings, including hospitals, nursing homes, and outpatient facilities, and encourages partnerships with public health departments and relevant entities. Interested applicants can apply for funding ranging from $2.5 million to $15 million, with an estimated total program funding of $750 million and an expected ten awards. Applications must be submitted electronically by June 5, 2026, with the anticipated award date set for August 1, 2026. For further inquiries, applicants may contact Carla Doan at gon5@cdc.gov or by phone at 770-488-8354.